Clinical Trial Update: This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS) [Phase 3]

View source ↗

Summary

This document describes an extension Phase 3 study evaluating the safety and effectiveness of ocrelizumab in participants with multiple sclerosis. The study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrevus (ocrelizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED